Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fractyl Health, Inc., in a filing with the U.S. Securities and Exchange Commission, on Monday said it expects to price the initial public offering or IPO of 7.33 million shares to be between $14.
FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural...
Osteoboost is the first and only non-pharmacological prescription treatment to demonstrate reduced loss of bone strength in postmenopausal womenRepresents the first therapeutic mechanism specifically designed and cleared for intervention during the osteopenia stageREDWOOD CITY, CA / ACCESSWIRE / January 18, 2024 / B...
/PRNewswire/ -- In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin...
WATERTOWN, Mass., Jan. 12, 2024 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are...